Federal Schedule III shift triggers D.C., Maryland cannabis uncertainty – Outlaw Report

Federal rescheduling of cannabis to Schedule III would fundamentally change how physicians approach cannabis medicine, moving from state recommendations to federal prescriptions. This regulatory shift creates both opportunities for standardized cannabis therapeutics and uncertainty during the transition period. Understanding these cannabis schedule iii medical implications helps patients and clinicians prepare for evolving treatment protocols.

Read More